Suchergebnisse - "Heske, Christine M"

PubPharm (21)

1

Enhancing standard of care chemotherapy efficacy using DNA-dependent protein kinase (DNA-PK) inhibition in preclinical models of Ewing sarcoma

enthalten in: Molecular cancer therapeutics | 2024

von Collins, V. | Ludwig, K. | Nelson, A. | +9

2

Stress biology : Complexity and multifariousness in health and disease

enthalten in: Cell stress & chaperones | 2024

von Mayer, M. | Blair, L. | Blatch, G. | +35

3

Inhibition of NAD+-Dependent Metabolic Processes Induces Cellular Necrosis and Tumor Regression in Rhabdomyosarcoma Models

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von McKay-Corkum, G. | Collins, V. | Yeung, C. | +18

4

Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Akshintala, S. | Sundby, R. | Bernstein, D. | +19

5

Impact of race and ethnicity on presentation and outcomes of patients treated on rhabdomyosarcoma clinical trials : A report from the Children's Oncology Group

enthalten in: Cancer medicine | 2023

von Munnikhuysen, S. | Ekpo, P. | Xue, W. | +4

6

Impact of race and ethnicity on presentation and outcomes of patients treated on rhabdomyosarcoma clinical trials : A report from the Children's Oncology Group

enthalten in: Cancer Medicine | 2023

von Munnikhuysen, S. | Ekpo, P. | Xue, W. | +4

7

An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children's Oncology Group clinical trials

enthalten in: Pediatric blood & cancer | 2022

von Haduong, J. | Heske, C. | Allen-Rhoades, W. | +7

8

An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children's Oncology Group clinical trials

enthalten in: Pediatric Blood & Cancer | 2022

von Haduong, J. | Heske, C. | Allen‐Rhoades, W. | +7

9

Prioritization of Novel Agents for Patients with Rhabdomyosarcoma : A Report from the Children's Oncology Group (COG) New Agents for Rhabdomyosarcoma Task Force

enthalten in: Journal of clinical medicine | 2021

von Pacenta, H. | Allen-Rhoades, W. | Langenau, D. | +18

10

Survival outcomes of patients with localized FOXO1 fusion-positive rhabdomyosarcoma treated on recent clinical trials : A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group

enthalten in: Cancer | 2021

von Heske, C. | Chi, Y. | Venkatramani, R. | +6